000661.SZ
长春高新
SZSE · Healthcare · C 制造业 · CN
CNY 76.11
−4.26%Year over year
Reported trailing growth
- Revenue
- -12.1%
- EBITDA
- —
- EBIT
- -93.5%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -47.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.5%
- EBITDA
- -40.0%
- EBIT
- -57.1%
- Net income
- -66.5%
- EPS
- -66.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026